Anurag Sharma

Anurag Sharma joined CBER/FDA in 2018, and currently oversees review of the CMC aspects of diverse gene therapy products as Branch Chief at Office of Therapeutic Products. Earlier, Anurag earned his bachelor’s degree in veterinary sciences and master’s in animal biotechnology from India before moving to the United States to pursue PhD in Molecular Virology from Purdue University at West Lafayette, IN. His doctoral research primarily focused on the development and characterization of novel adenoviral vectors for gene delivery applications. After his PhD, Anurag worked at Weill Cornell Medicine (WCM) at New York City as a postdoctoral associate and subsequently as an Assistant Professor of Research. At WCM, he continued his research to design innovative strategies to further improve adenoviral vectors and to develop vaccines against some of the pediatric respiratory infections with no approved vaccines. He also holds Regulatory Affairs Certification (RAC US) offered by Regulatory Affairs Professional Society (RAPS).

Appearances

This speaker has made no appearances.